LC9 Scores Tied to Better Lung Health in NHANES Analysis
Cross-sectional study linked higher cardiovascular health scores with fewer respiratory symptoms and higher lung function measures among US adults
By
Andrea Surnit
May 19, 2026
Clinical Scorecard: LC9 Scores Tied to Better Lung Health in NHANES Analysis
At a Glance
Category Detail
Condition Respiratory symptoms and chronic lung disease
Key Mechanisms Life’s Crucial 9 (LC9) score incorporates diet, physical activity, nicotine exposure, sleep, body mass index, blood pressure, blood glucose, blood lipids, and mental health.
Target Population US adults aged 40 years and older
Care Setting Cross-sectional analysis using NHANES data
Key Highlights
Higher LC9 scores associated with lower prevalence of respiratory symptoms and chronic lung diseases. Every 10-point increase in LC9 score linked to lower odds of cough, phlegm, wheeze, asthma, emphysema, chronic bronchitis, and COPD. Emphysema prevalence was 7% in low cardiovascular health vs <1% in high cardiovascular health. Associations between LC9 and lung function measures stronger among older patients and men. Machine learning models showed strong predictive performance for emphysema.
Guideline-Based Recommendations
Diagnosis
Respiratory symptoms and diagnoses based on self-report. COPD confirmed if FEV1/FVC ratio remains below 0.7 after bronchodilator.
Management
Consider LC9 as a framework for lifestyle management in patients with cardiovascular and respiratory risk factors.
Monitoring & Follow-up
Monitor LC9 scores and associated respiratory outcomes.
Risks
Potential recall bias in self-reported respiratory outcomes. Selection bias from exclusion of patients with missing data.
Patient & Prescribing Data
Adults aged 40 years and older from NHANES data.
Higher LC9 scores correlate with better lung health outcomes.
Clinical Best Practices
Encourage lifestyle modifications to improve LC9 scores. Utilize machine learning models for predicting respiratory disease risk.
Related Resources & Content